Anhui Anke BioTech Group (300009) — Net Asset Quality Index
Anhui Anke BioTech Group (300009) has a Net Asset Quality Index of 85.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.10 Billion minus total liabilities of CN¥755.64 Million yields net assets of CN¥4.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300009 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anhui Anke BioTech Group Net Asset Quality Index Over Time (2006–2024)
This chart shows how Anhui Anke BioTech Group's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 85.2%, representing net assets of CN¥4.34 Billion against total assets of CN¥5.10 Billion CNY. See how liquid is Anhui Anke BioTech Group's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Anhui Anke BioTech Group (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Anhui Anke BioTech Group from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300009 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.7% | CN¥4.30 Billion | CN¥5.14 Billion | CN¥835.41 Million | ▲ +4.3 pp |
| 2023 | 79.4% | CN¥3.93 Billion | CN¥4.95 Billion | CN¥1.02 Billion | ▼ -0.5 pp |
| 2022 | 79.9% | CN¥3.40 Billion | CN¥4.26 Billion | CN¥853.62 Million | ▲ +0.8 pp |
| 2021 | 79.1% | CN¥2.90 Billion | CN¥3.67 Billion | CN¥765.52 Million | ▼ -4.4 pp |
| 2020 | 83.6% | CN¥2.93 Billion | CN¥3.50 Billion | CN¥576.29 Million | ▼ -0.1 pp |
| 2019 | 83.7% | CN¥2.70 Billion | CN¥3.23 Billion | CN¥526.19 Million | ▲ +4.1 pp |
| 2018 | 79.6% | CN¥2.01 Billion | CN¥2.53 Billion | CN¥515.86 Million | ▲ +1.5 pp |
| 2017 | 78.1% | CN¥1.76 Billion | CN¥2.25 Billion | CN¥493.73 Million | ▲ +5.5 pp |
| 2016 | 72.6% | CN¥1.43 Billion | CN¥1.97 Billion | CN¥539.04 Million | ▼ -17.7 pp |
| 2015 | 90.2% | CN¥1.26 Billion | CN¥1.40 Billion | CN¥136.82 Million | ▲ +5.8 pp |
| 2014 | 84.5% | CN¥773.47 Million | CN¥915.58 Million | CN¥142.11 Million | ▼ -3.6 pp |
| 2013 | 88.1% | CN¥660.60 Million | CN¥749.81 Million | CN¥89.21 Million | ▼ -0.7 pp |
| 2012 | 88.8% | CN¥580.03 Million | CN¥652.93 Million | CN¥72.91 Million | ▼ -1.3 pp |
| 2011 | 90.1% | CN¥543.88 Million | CN¥603.65 Million | CN¥59.77 Million | ▲ +1.5 pp |
| 2010 | 88.6% | CN¥522.30 Million | CN¥589.55 Million | CN¥67.25 Million | ▼ -2.8 pp |
| 2009 | 91.3% | CN¥495.41 Million | CN¥542.36 Million | CN¥46.95 Million | ▲ +24.7 pp |
| 2008 | 66.7% | CN¥148.64 Million | CN¥222.96 Million | CN¥74.32 Million | ▲ +8.7 pp |
| 2007 | 58.0% | CN¥137.09 Million | CN¥236.55 Million | CN¥99.46 Million | ▲ +3.9 pp |
| 2006 | 54.0% | CN¥122.00 Million | CN¥225.72 Million | CN¥103.72 Million | — |